CSTL
Price
$37.16
Change
-$1.35 (-3.51%)
Updated
Oct 30 closing price
Capitalization
1.14B
5 days until earnings call
Intraday BUY SELL Signals
OFIX
Price
$9.07
Change
-$1.17 (-11.43%)
Updated
Oct 30 closing price
Capitalization
369.44M
9 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSTL vs OFIX

CSTL vs OFIX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CSTL vs. OFIX commentary
Nov 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Buy and OFIX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CSTL with price predictions
Oct 30, 2026

CSTL in upward trend: 10-day moving average broke above 50-day moving average on October 30, 2026

The 10-day moving average for CSTL crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on CSTL as a result. In 75 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for CSTL just turned positive on October 27, 2026. Looking at past instances where CSTL's MACD turned positive, the stock continued to rise in 31 of 37 cases over the following month. The odds of a continued upward trend are 84%.

CSTL moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +11.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in 231 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

The Aroon Indicator entered an Uptrend today. In 206 of 227 cases where CSTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for CSTL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 32 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

CSTL broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.415) is normal, around the industry mean (67.473). P/E Ratio (-58.062) is within average values for comparable stocks, (2.957). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.947) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

A.I.Advisor
a Summary for OFIX with price predictions
Oct 30, 2026

Aroon Indicator for OFIX shows an upward move is likely

OFIX's Aroon Indicator triggered a bullish signal on October 26, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 149 similar instances where the Aroon Indicator showed a similar pattern. In 126 of the 149 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for OFIX crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 23 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 74%.

Following a +5.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where OFIX advanced for three days, in 203 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 57 cases where OFIX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.

The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OFIX as a result. In 72 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

OFIX moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

OFIX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. OFIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.861) is normal, around the industry mean (4.201). P/E Ratio (-5.967) is within average values for comparable stocks, (1.335). OFIX's Projected Growth (PEG Ratio) (48.825) is slightly higher than the industry average of (11.052). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (0.431) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
CSTL vs OFIX: Fundamental Ratings
CSTL
OFIX
OUTLOOK RATING
1..100
369
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9294
PRICE GROWTH RATING
1..100
3661
P/E GROWTH RATING
1..100
9122
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSTL's Valuation (20) in the null industry is significantly better than the same rating for OFIX (99) in the Medical Specialties industry. This means that CSTL’s stock grew significantly faster than OFIX’s over the last 12 months.

CSTL's Profit vs Risk Rating (100) in the null industry is in the same range as OFIX (100) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to OFIX’s over the last 12 months.

CSTL's SMR Rating (92) in the null industry is in the same range as OFIX (94) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to OFIX’s over the last 12 months.

CSTL's Price Growth Rating (36) in the null industry is in the same range as OFIX (61) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to OFIX’s over the last 12 months.

OFIX's P/E Growth Rating (22) in the Medical Specialties industry is significantly better than the same rating for CSTL (91) in the null industry. This means that OFIX’s stock grew significantly faster than CSTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSTLOFIX
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
COMPARISON
Comparison
Nov 01, 2026
Stock price -- (CSTL: $37.16 vs. OFIX: $9.07)
Brand notoriety: CSTL and OFIX are both not notable
CSTL represents the Medical Specialties, while OFIX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CSTL: 103% vs. OFIX: 164%
Market capitalization -- CSTL: $1.14B vs. OFIX: $369.44M
CSTL [@Medical Specialties] is valued at $1.14B. OFIX’s [@Medical/Nursing Services] market capitalization is $369.44M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $183.77B. The average market capitalization across the [@Medical Specialties] industry is $21.72B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 1 FA rating(s) are green while OFIX’s FA Score has 1 green FA rating(s).

  • CSTL’s FA Score: 1 green, 4 red.
  • OFIX’s FA Score: 1 green, 4 red.
According to our system of comparison, CSTL is a better buy in the long-term than OFIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 6 TA indicator(s) are bullish while OFIX’s TA Score has 3 bullish TA indicator(s).

  • CSTL’s TA Score: 6 bullish, 4 bearish.
  • OFIX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CSTL is a better buy in the short-term than OFIX.

Price Growth

CSTL (@Medical Specialties) experienced а +12.33% price change this week, while OFIX (@Medical/Nursing Services) price change was -7.54% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.12%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +48.45%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.04%. For the same industry, the average monthly price growth was -8.74%, and the average quarterly price growth was -9.59%.

Reported Earning Dates

CSTL is expected to report earnings on Nov 05, 2026.

OFIX is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Medical Specialties (+2.12% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (+0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
CSTL
Daily Signal:
Gain/Loss:
OFIX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CSTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with TCMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
-3.51%
TCMD - CSTL
50%
Loosely correlated
-5.22%
NEO - CSTL
48%
Loosely correlated
-3.07%
GH - CSTL
44%
Loosely correlated
-3.51%
ADPT - CSTL
44%
Loosely correlated
-5.43%
NTRA - CSTL
41%
Loosely correlated
-4.98%
More

OFIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, OFIX has been loosely correlated with ENOV. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if OFIX jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OFIX
1D Price
Change %
OFIX100%
-11.43%
ENOV - OFIX
50%
Loosely correlated
-12.71%
SIBN - OFIX
46%
Loosely correlated
-5.27%
MMSI - OFIX
46%
Loosely correlated
-7.66%
SYK - OFIX
46%
Loosely correlated
-6.38%
CSTL - OFIX
45%
Loosely correlated
-3.51%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XC29.77-0.36
-1.21%
WisdomTree True Emerging Markets Fund (XC)
FEAC32.48-0.50
-1.52%
Fidelity Enhanced U.S. All-Cap Equity ETF
LDRX36.01-0.75
-2.03%
SGI Enhanced Market Leaders ETF (LDRX)
VUG85.06-2.63
-3.00%
Vanguard Morningstar Growth ETF (VUG)
ETHB28.75-1.28
-4.26%
iShares Staked Ethereum Trust ETF (ETHB)